- Design
- Nested case-control study, UK primary care (CPRD Gold and Aurum)
- Population
- 218,056 men with POAG and 876,872 matched controls
- Primary outcome
- Association of erectile dysfunction medication with POAG
- Effect
- OR 1.29 (1.25–1.32) Gold; OR 1.17 (1.15–1.18) Aurum
This nested case-control study, published in the British Journal of Ophthalmology on 11 September, used two UK primary care databases. It compared 218,056 men with primary open-angle glaucoma with 876,872 matched controls.
Erectile dysfunction medication had been prescribed to 20% of cases and 17% of controls. After adjustment for age, ethnicity and deprivation, use was associated with higher glaucoma risk (OR 1.29 in one database, 1.17 in the other). Older age, Black or Asian ethnicity, hypertension, diabetes, asthma, migraine and sickle cell disease were also associated with glaucoma.
The authors read this as a marker of vascular disease rather than a drug effect, since these medicines are taken on demand. It is an association adjusted for few confounders, and it gives no reason to withhold treatment for erectile dysfunction.
- Do not stop erectile dysfunction treatment because of this finding.
- Consider erectile dysfunction a possible marker of vascular risk relevant to glaucoma.
- Keep glaucoma screening focused on age, ethnicity and family history.
- Ask men with vascular risk factors when their eyes were last checked.
Why it matters
It adds indirect support to a vascular contribution to open-angle glaucoma.
Don't overread it
This was observational with limited adjustment; it does not show that the drugs cause glaucoma.
The statistics, in plain English
Odds ratios of 1.17 to 1.29 mean modestly higher odds, about a fifth. With nearly a million men, the intervals are narrow, but narrow intervals do not remove confounding by vascular disease.
Read the rest in the app
You have read your two free briefings this month. The app carries all 27 specialties, every morning, free — and this finding is waiting in it.

Scan to keep reading on your phone. No account needed to start.
Tomorrow morning, before your first patient
One edition a day for ophthalmology, written by the desk, every claim tied to its paper. Six minutes.
Get the app — free